preprint · 2025
The Use of Angiotensin-Converting Enzyme Inhibitors in Hospitalized Patients With COVID-19 Is Associated With a Lower Risk of Mortality
INTRODUCTION: The relationship between the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), diabetes mell...
0 citationsDOI: https://doi.org/10.32388/47oo14Open accessPDF reported by metadataFull text reported by metadata